SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

LYTIX (LYTIX) News

Track canonical SquawkNews coverage tagged to LYTIX, LYTIX. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol LYTIX Asset market Sector Markets 90 days 1 Updated Aug 27, 2026, 05:04 AM UTC Open live news feed
M Lytix gets FDA Phase III clearance for ruxotemitide FDA cleared Phase III for ruxotemitide. Lytix says its cash position supports advancing the clinical pipeline. REGULATION | Aug 27, 2026, 05:04 AM UTC